Related Experiment Video
Updated: May 15, 2026

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
Published on: August 19, 2014
Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability
11] The Hormel Institute, University of Minnesota, Austin, MN, USA [2] State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, Xïan, China.
Abstract:
RNF2, also known as Ring1B/Ring2, is a component of the polycomb repression complex 1. RNF2 is highly expressed in many tumors, suggesting that it might have an oncogenic function, but the mechanism is unknown. Here, we show that knockdown of RNF2 significantly inhibits both cell proliferation and colony formation in soft agar, and induces apoptosis in cancer cells. Knockdown of RNF2 in HCT116 p53(+/+) cells resulted in significantly more apoptosis than was observed in RNF2 knockdown HCT116 p53(-/-) cells, indicating that RNF2 knockdown-induced apoptosis is partially dependent on p53. Various p53-targeted genes were increased in RNF2 knockdown cells. Further studies revealed that in RNF2 knockdown cells, the p53 protein level was increased, the half-life of p53 was prolonged and p53 ubiquitination was decreased. In contrast, cells overexpressing RNF2 showed a decreased p53 protein level, a shorter p53 half-life and increased p53 ubiquitination. Importantly, we found that RNF2 directly binds with both p53 and MDM2 and promotes MDM2-mediated p53 ubiquitination. RNF2 overexpression could also increase the half-life of MDM2 and inhibit its ubiquitination. The regulation on p53 and MDM2 stability by RNF2 was also observed during the etoposide-induced DNA damage response. These results provide a possible mechanism explaining the oncogenic function of RNF2, and because RNF2 is important for cancer cell survival and proliferation, it might be an ideal target for cancer therapy or prevention.
Insights
Ring1B/Ring2 (RNF2) promotes cancer cell survival by stabilizing p53 protein levels and inhibiting its degradation. Targeting RNF2 may offer a new strategy for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Ring1B/Ring2 (RNF2) is a component of the polycomb repression complex 1.
- RNF2 is highly expressed in numerous tumors, implying an oncogenic role.
- The precise mechanism behind RNF2's oncogenic function remains largely unknown.
Purpose of the Study:
- To elucidate the mechanism by which RNF2 contributes to cancer cell proliferation and survival.
- To investigate the role of RNF2 in regulating the stability of the tumor suppressor protein p53.
- To explore the potential of RNF2 as a therapeutic target in cancer treatment.
Main Methods:
- RNF2 knockdown and overexpression in cancer cell lines (HCT116).
- Assessment of cell proliferation, colony formation, and apoptosis.
- Analysis of p53 and MDM2 protein levels, half-life, and ubiquitination.
- Co-immunoprecipitation assays to determine direct binding interactions.
Main Results:
- RNF2 knockdown inhibited cancer cell proliferation and induced apoptosis, partially dependent on p53.
- RNF2 knockdown increased p53 protein levels and half-life by decreasing its ubiquitination.
- RNF2 directly binds to p53 and MDM2, promoting MDM2-mediated p53 ubiquitination.
- RNF2 overexpression decreased p53 and MDM2 protein levels and increased their ubiquitination.
Conclusions:
- RNF2 promotes cancer cell survival and proliferation by enhancing p53 degradation through MDM2.
- RNF2's oncogenic function is mediated by its regulation of p53 and MDM2 stability.
- RNF2 represents a promising therapeutic target for cancer treatment and prevention.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

